QIAGEN Website    Quick Order    Online Seminar    Contact    My Account
Bookmark and Share Home  >  Resources  >  Online Seminars

For the most updated product information, visit GeneGlobe on QIAGEN website

Online Seminars

SABiosciences is pleased to provide free, on-line educational resources covering relevant tools and techniques for gene and protein expression analysis, and cell-based gene function analysis. We offer live webinars, prerecorded and PDF formatted presentations.

See the instructions for the Web Seminars

July 2012
Monday
Tuesday
Wednesday
Thursday
Friday

2

PCR Arrays forPathway Analysis

3

Identify key players and regulators in cancer

4

5

PCR Array Data Analysis Tutorial

6

Functional analysis of genes, biologics & small molecules

9

RNAi Screen Design & Optimzation

10

Epigenetic Technologies for Biomedical Research

11

Innate immune system

QPCR Introduction

12

ChIP and Real-Time PCR Technology Overview

13

Oncogenomics & cancer mutation

16

Cell Death Research Solutions

17

Wnt Signaling Research Solutions

18

Gene Network Central Tutorial

Research tools for inflammation regulation

19

Anticancer Immunity

20

Copy number: variation & alteration analysis strategies

23

Metabolism and cancer

24

Wnt application- a case study

25

Profiling DNA Methylation with PCR System

PCR Array Data Analysis Tutorial

26

RNAi Gene Knockdown with shRNA

27

Oncogenomics & cancer mutation

miRNA Expression and Function

30

Signal transduction targets

31

Cancer and Inflammation

Current Seminar Titles Available:

Focus Title
1.  RNA-seq Explorer solutionTranscriptome analysis of Kupffer cells after uptake of pancreatic cancer exosomes reveal pathways and biological processes involved in metastatic progression
2.  AdnaTestsThe Her2 miracle in CTCs and its correlation to EMT and tumor stemness

Transcriptome analysis of Kupffer cells after uptake of pancreatic cancer exosomes reveal pathways and biological processes involved in metastatic progression

Pancreatic cancer is one of the most lethal malignancies with a poor prognosis. Understanding the mechanisms of tumor progression is therefore essential. Liquid biopsies are non-invasive methods for diagnostics to detect early stage cancer resulting in more successful treatment. One liquid biopsy technique is the detection of RNA from tumor- derived exosomes. These exosomes participate in generating a metastatic niche. Using QIAGEN Bioinformatics solutions with a publicly available dataset we have examined the transcriptome of Kupffer cells after uptake of pancreatic tumor-derived exosomes that induce the formation of a liver metastatic niche and analyzed the pathways and biological processes involved in this process.

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, February 22, 2017 at 1:00 PM Eastern    Status: Available Reserve

The Her2 miracle in CTCs and its correlation to EMT and tumor stemness

"Breast cancer is the most common cancer in women, accounting for 23% of all cancer diagnoses. Early detection of breast cancer metastasis would allow for changes in treatment strategy before the disease progression becomes apparent. In this webinar, we will demonstrate the enrichment and detection value as well as the prognostic and predictive value of the AdnaTestBreast in breast cancer. Using the Combination of Combinations Principle (COCP), AdnaTest BreastCancer enables highly specific immunomagnetic cell selection for enriching circulating tumor cells (CTCs) from peripheral blood. It also allows sensitive analysis of breast cancer-associated gene expression in enriched CTCs by reverse transcription and PCR. The high performance of AdnaTest BreastCancer has been demonstrated in dozens of peer-reviewed publications. Several studies have reported that HER2 expression is different in primary tumors compared to CTCs. In addition, AdnaTestBreast HER2 overexpression profile corresponds to HER2 metastatic phenotype; and HER2 detected by the AdnaTestBreast and AdnaTest EMT-2/StemCell seems to initiate EMT and tumor stemness."

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, February 23, 2017 at 1:00 PM Eastern    Status: Available Reserve
Monday, February 27, 2017 at 9:30 AM Eastern    Status: Available Reserve

Note: Viewers will be asked to register before viewing the previously recorded webinars.